tradingkey.logo
tradingkey.logo
Search

Journey Medical Corp

DERM
Add to Watchlist
6.600USD
-0.050-0.75%
Market hours ETQuotes delayed by 15 min
179.15MMarket Cap
LossP/E TTM

DERM Income Statement

You can find the annual or quarterly income statement of Journey Medical Corp here for insights into the performance and operational efficiency of Journey Medical Corp.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2020Q2
Total revenue
23.33%18.51M
21.48%15.96M
18.05%16.08M
20.52%17.63M
1.04%15.01M
0.84%13.14M
-10.73%13.62M
-57.64%14.63M
-13.49%14.86M
6.69%13.03M
-4.44%15.26M
114.31%34.54M
-6.12%17.17M
-47.57%12.21M
-8.85%15.97M
-17.82%16.12M
19.64%18.29M
--23.30M
--17.52M
--19.61M
62.38%15.29M
--9.41M
Revenue
18.86%17.84M
21.17%15.92M
27.31%16.07M
16.38%17.02M
1.04%15.01M
0.84%13.14M
-17.28%12.62M
-4.25%14.63M
-12.42%14.86M
7.11%13.03M
-4.17%15.26M
-4.76%15.28M
-6.99%16.96M
-41.50%12.16M
-9.11%15.92M
-18.19%16.04M
19.28%18.23M
--20.80M
--17.52M
--19.61M
--15.29M
----
Cost of revenue
18.47%7.11M
25.43%7.34M
14.91%6.50M
29.03%6.82M
-8.23%6.00M
-14.10%5.86M
-5.89%5.66M
-17.79%5.29M
-15.78%6.54M
5.69%6.82M
-22.07%6.01M
-10.97%6.43M
1.76%7.77M
-21.38%6.45M
-18.97%7.72M
-35.34%7.22M
1.99%7.63M
--8.20M
--9.53M
--11.17M
139.56%7.48M
--3.12M
Operating expenses
0.94%18.05M
6.01%17.45M
3.66%16.52M
9.34%19.16M
0.58%17.89M
-28.79%16.46M
-8.19%15.94M
1.32%17.52M
-17.99%17.78M
6.18%23.12M
-33.13%17.36M
-32.47%17.29M
-14.75%21.68M
-9.13%21.77M
-2.31%25.96M
-20.61%25.61M
-12.45%25.43M
--23.96M
--26.57M
--32.26M
268.85%29.05M
--7.88M
R&D expenses
--54.00K
-100.00%0.00
-29.36%154.00K
-65.91%287.00K
-100.00%0.00
-99.51%39.00K
-85.51%218.00K
-62.23%842.00K
-48.53%913.00K
287.80%7.88M
-64.64%1.50M
-20.73%2.23M
-32.00%1.77M
60.58%2.03M
113.65%4.26M
254.16%2.81M
-81.06%2.61M
--1.27M
--1.99M
--794.00K
--13.77M
--0.00
Depreciation, depletion, and amortization
----
5.73%1.13M
8.56%1.06M
30.71%1.06M
30.55%1.06M
30.84%1.06M
20.37%981.00K
0.00%814.00K
-23.76%815.00K
-23.85%814.00K
--815.00K
--814.00K
--1.07M
--1.07M
----
----
----
----
--500.00K
--700.00K
----
----
Other operating expenses
----
----
123.39%1.06M
----
----
----
---4.55M
----
----
----
----
----
----
----
--0.00
-100.00%0.00
----
---223.00K
--0.00
--9.54M
----
----
Operating profit
115.86%456.00K
55.11%-1.49M
80.90%-443.00K
47.17%-1.53M
1.74%-2.88M
67.06%-3.32M
-10.22%-2.32M
-116.78%-2.89M
35.10%-2.93M
-5.53%-10.09M
78.95%-2.10M
281.68%17.25M
36.85%-4.51M
-1337.74%-9.56M
-10.36%-9.99M
24.94%-9.49M
48.11%-7.14M
---665.00K
---9.06M
---12.65M
-994.28%-13.76M
--1.54M
Net non-operating interest income (expenses)
Non-operating interest income
11.59%154.00K
5.37%157.00K
-22.51%148.00K
-18.09%154.00K
-14.29%138.00K
-31.34%149.00K
69.03%191.00K
2250.00%188.00K
103.80%161.00K
77.87%217.00K
126.00%113.00K
166.67%8.00K
1875.00%79.00K
3966.67%122.00K
2400.00%50.00K
--3.00K
--4.00K
--3.00K
--2.00K
----
----
----
Non-operating interest expense
-3.31%906.00K
0.11%892.00K
12.27%933.00K
23.61%937.00K
66.43%937.00K
62.59%891.00K
3362.50%831.00K
182.84%758.00K
-25.53%563.00K
-15.69%548.00K
-96.11%24.00K
-52.06%268.00K
66.52%756.00K
67.10%650.00K
-84.94%617.00K
-59.29%559.00K
-66.17%454.00K
--389.00K
--4.10M
--1.37M
765.81%1.34M
--155.00K
Gains from sale of securities
98.36%-1.00K
57.14%-3.00K
-58.33%-19.00K
94.12%-3.00K
-90.63%-61.00K
66.67%-7.00K
-500.00%-12.00K
49.50%-51.00K
3.03%-32.00K
55.32%-21.00K
97.01%-2.00K
-359.09%-101.00K
---33.00K
---47.00K
---67.00K
---22.00K
----
----
----
----
----
----
Special income (expenses)
----
----
-100.00%0.00
----
----
----
--4.55M
--1.13M
100.00%0.00
----
--0.00
--0.00
---3.14M
----
100.00%0.00
100.00%0.00
100.00%0.00
---223.00K
---263.00K
---2.00K
---182.00K
--0.00
Income before tax
92.05%-297.00K
45.25%-2.23M
-178.82%-1.25M
3.14%-2.31M
-11.16%-3.74M
60.99%-4.07M
178.43%1.58M
-114.16%-2.39M
59.81%-3.36M
-3.02%-10.44M
81.02%-2.02M
267.67%16.88M
-10.16%-8.36M
-695.60%-10.14M
20.77%-10.63M
28.18%-10.07M
50.34%-7.59M
---1.27M
---13.42M
---14.02M
-1204.55%-15.29M
--1.38M
Income tax
-75.00%15.00K
--0.00
-100.00%0.00
--0.00
--60.00K
--0.00
-51.59%61.00K
-100.00%0.00
--0.00
--0.00
869.23%126.00K
850.00%95.00K
100.00%0.00
-100.00%0.00
-99.84%13.00K
100.30%10.00K
98.13%-64.00K
--104.00K
--8.34M
---3.38M
-468.35%-3.42M
--929.00K
Income after tax
91.78%-312.00K
45.25%-2.23M
-181.99%-1.25M
3.14%-2.31M
-12.94%-3.80M
60.99%-4.07M
170.98%1.52M
-114.24%-2.39M
59.81%-3.36M
-3.02%-10.44M
79.86%-2.14M
266.56%16.79M
-11.09%-8.36M
-635.56%-10.14M
51.07%-10.64M
5.32%-10.08M
36.55%-7.53M
---1.38M
---21.75M
---10.65M
-2707.69%-11.87M
--455.00K
Net income from continuous operations
----
45.25%-2.23M
-181.99%-1.25M
3.14%-2.31M
-12.94%-3.80M
60.99%-4.07M
170.98%1.52M
-114.24%-2.39M
59.81%-3.36M
-3.02%-10.44M
79.86%-2.14M
266.56%16.79M
-11.09%-8.36M
-635.56%-10.14M
51.07%-10.64M
5.32%-10.08M
36.55%-7.53M
---1.38M
---21.75M
---10.65M
-2707.69%-11.87M
--455.00K
Net income attributable to controlling interests
----
45.25%-2.23M
-181.99%-1.25M
3.14%-2.31M
-12.94%-3.80M
60.99%-4.07M
170.98%1.52M
-114.24%-2.39M
59.81%-3.36M
-3.02%-10.44M
79.86%-2.14M
266.56%16.79M
-11.09%-8.36M
-635.56%-10.14M
51.07%-10.64M
5.32%-10.08M
36.55%-7.53M
---1.38M
---21.75M
---10.65M
-2707.69%-11.87M
--455.00K
Net income attributable to common shareholders
----
45.25%-2.23M
-181.99%-1.25M
3.14%-2.31M
-12.94%-3.80M
60.99%-4.07M
170.98%1.52M
-114.24%-2.39M
59.81%-3.36M
-3.02%-10.44M
79.86%-2.14M
266.56%16.79M
-11.09%-8.36M
-635.56%-10.14M
51.07%-10.64M
5.32%-10.08M
36.55%-7.53M
---1.38M
---21.75M
---10.65M
-2707.69%-11.87M
--455.00K
Basic earnings per share
93.86%-0.01
54.66%-0.08
-164.47%-0.05
20.30%-0.09
3.05%-0.16
65.92%-0.18
162.26%0.07
-112.77%-0.12
63.81%-0.17
7.15%-0.53
80.90%-0.11
259.34%0.91
-7.70%-0.46
-615.36%-0.57
63.36%-0.60
50.77%-0.57
40.24%-0.43
---0.08
---1.64
---1.16
-2708.10%-0.72
--0.03
Diluted earnings per share
93.86%-0.01
54.66%-0.08
-164.47%-0.05
20.30%-0.09
3.05%-0.16
65.92%-0.18
162.26%0.07
-114.58%-0.12
63.81%-0.17
7.15%-0.53
80.90%-0.11
239.50%0.80
-7.70%-0.46
-615.36%-0.57
63.36%-0.60
50.77%-0.57
-159.76%-0.43
---0.08
---1.64
---1.16
2708.10%0.72
---0.03
Dividend per share
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Journey Medical Corp's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing DERM stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Journey Medical Corp's revenue at year end?

Journey Medical Corp reported 61.86M in revenue for fiscal year 2025, up from 56.13M in the previous year.

How much revenue did Journey Medical Corp report in the most recent quarter?

Journey Medical Corp reported 18.51M in revenue for the most recent quarter, an increase of 23.33% year over year.

What was Journey Medical Corp's net income for the year?

Journey Medical Corp posted -11.43M in net income for fiscal year 2025.

What was Journey Medical Corp's annual operating profit?

Journey Medical Corp's operating income was -8.17M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.